After losing some value lately, a hammer chart pattern has been formed for Guardant Health (GH), indicating that the stock has found support. This, combined with an upward trend in earnings estimate ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating ...
Guardant Health (NASDAQ:GH), a $5.49 billion market cap healthcare company, announced a significant step in its financial strategy, reaching an agreement to exchange a portion of its convertible notes ...
Craig-Hallum analyst William Bonello maintained a Buy rating on Guardant Health (GH – Research Report) today. The company’s shares closed ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it ...